These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9662243)

  • 1. A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.
    Gulliford T; English J; Colston KW; Menday P; Moller S; Coombes RC
    Br J Cancer; 1998 Jul; 78(1):6-13. PubMed ID: 9662243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation.
    Hansen CM; Hamberg KJ; Binderup E; Binderup L
    Curr Pharm Des; 2000 May; 6(7):803-28. PubMed ID: 10828309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
    Takahashi F; Furuichi T; Yorozu K; Kawata S; Kitamura H; Kubodera N; Slatopolsky E
    Nephrol Dial Transplant; 2002; 17 Suppl 10():46-52. PubMed ID: 12386269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
    Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
    Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.
    Colston KW; Mackay AG; James SY; Binderup L; Chander S; Coombes RC
    Biochem Pharmacol; 1992 Dec; 44(12):2273-80. PubMed ID: 1472092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2).
    Fan SL; Schroeder NJ; Calverley MJ; Burrin JM; Makin HL; Cunningham J
    Nephrol Dial Transplant; 2000 Dec; 15(12):1943-9. PubMed ID: 11096138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.
    Colston KW; Pirianov G; Bramm E; Hamberg KJ; Binderup L
    Breast Cancer Res Treat; 2003 Aug; 80(3):303-11. PubMed ID: 14503802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
    Roy S; Martel J; Tenenhouse HS
    J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats.
    Hirata M; Endo K; Ohkawa H; Kumaki K; Kubodera N; Slatopolsky E; Kurokawa K; Fukagawa M
    Nephrol Dial Transplant; 2002; 17 Suppl 10():37-40. PubMed ID: 12386267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.
    Liu G; Oettel K; Ripple G; Staab MJ; Horvath D; Alberti D; Arzoomanian R; Marnocha R; Bruskewitz R; Mazess R; Bishop C; Bhattacharya A; Bailey H; Wilding G
    Clin Cancer Res; 2002 Sep; 8(9):2820-7. PubMed ID: 12231522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.
    Peehl DM; Seto E; Hsu JY; Feldman D
    J Urol; 2002 Oct; 168(4 Pt 1):1583-8. PubMed ID: 12352462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-(OH)2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect.
    Lippuner K; Perrelet R; Casez JP; Popp A; Uskokovic MR; Jaeger P
    Horm Res; 2004; 61(1):7-16. PubMed ID: 14646396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EB 1089, a calcitriol analogue, decreases fetal calcium content when injected into pregnant rats.
    Davicco MJ; Coxam V; Gaumet N; Lebecque P; Barlet JP
    Exp Physiol; 1995 May; 80(3):449-56. PubMed ID: 7640009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.